School of Medicine


Showing 501-519 of 519 Results

  • Joseph  C. Wu, MD, PhD

    Joseph C. Wu, MD, PhD

    Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor and Professor of Radiology

    Current Research and Scholarly InterestsDrug discovery, drug screening, and disease modeling using iPSC.

  • Sean M. Wu

    Sean M. Wu

    Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Pediatrics

    Current Research and Scholarly InterestsMy lab seeks to identify mechanisms regulating cardiac lineage commitment during embryonic development and the biology of cardiac progenitor cells in development and disease. We believe that by understanding the transcriptional and epigenetic basis of cardiomyocyte growth and differentiation, we can identify the most effective ways to repair diseased adult hearts. We employ mouse and human embryonic and induced pluripotent stem cells as well as rodents as our in vivo models for investigation.

  • Joanna Wysocka

    Joanna Wysocka

    Lorry Lokey Professor and Professor of Developmental Biology

    Current Research and Scholarly InterestsThe precise and robust regulation of gene expression is a cornerstone for complex biological life. Research in our laboratory is focused on understanding how regulatory information encoded by the genome is integrated with the transcriptional machinery and chromatin context to allow for emergence of form and function during human embryogenesis and evolution, and how perturbations in this process lead to disease.

  • Fan Yang

    Fan Yang

    Associate Professor of Orthopaedic Surgery and of Bioengineering

    Current Research and Scholarly InterestsOur lab’s mission is to develop therapies for regenerating human tissues lost due to diseases or aging, and to build tissue engineered 3D models for understanding disease progression and informing drug discovery. We invent biomaterials and engineering tools to elucidate and modulate biology, and also use biology to inform materials and engineering design. Our work is highly interdisciplinary, and is driven by unmet clinical needs or key gaps in biology.

  • Phillip C. Yang, MD

    Phillip C. Yang, MD

    Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsDr. Yang is a physician-scientist whose research interest focuses on clinical translation of the fundamental molecular and cellular processes of myocardial restoration. His research employs novel in vivo multi-modality molecular and cellular imaging technology to translate the basic innovation in cardiovascular pluripotent stem cell biologics. Dr. Yang is currently a PI on the NIH/NHLBI funded CCTRN UM1 grant, which is designed to conduct multi-center clinical trial on novel biological therapy.

  • Yunzhi Peter Yang

    Yunzhi Peter Yang

    Professor of Orthopaedic Surgery and, by courtesy, of Materials Science and Engineering and of Bioengineering

    Current Research and Scholarly InterestsYang’ lab's research interests are in the areas of bio-inspired biomaterials, medical devices, and 3D printing approaches for re-creating a suitable microenvironment for cell growth and tissue regeneration for musculoskeletal disease diagnosis and treatment, including multiple tissue healing such as rotator cuff injury, orthopedic diseases such as osteoporosis and osteonecrosis, and orthopedic traumas such as massive bone and muscle injuries.

  • Alan Yeung, MD

    Alan Yeung, MD

    Li Ka Shing Professor in Cardiology

    Current Research and Scholarly InterestsCoronary artery disease is the leading cause of death in men and women in the United States. Our group is interested in studying both the early and late phases of atherosclerosis so that we can better develop prevention and treatment strategies.

  • Paul Yock, MD

    Paul Yock, MD

    Emeritus Faculty, Acad Council, Miscellaneous

    BioYock began his faculty career as an interventional cardiologist at UC San Francisco and then moved to Stanford in 1994. Yock is known for his work in inventing, developing and testing new devices, including the Rapid Exchange angioplasty and stenting system, which is the primary approach used worldwide. Yock also authored the fundamental patents for intravascular ultrasound imaging, conducted the initial clinical trials and established the Stanford Center for Research in Cardiovascular Interventions as a core laboratory for analysis of intravascular ultrasound clinical studies. He also invented the Smart Needle and is a co-inventor of the strain-reduction patch for wound healing. Yock was founding Co-Chair of the Department of Bioengineering and continues research related to new device technologies. Yock also was the founding director of the Stanford Byers Center for Biodesign -dedicated to advanced training in medical technology innovation.

  • Celina Yong, MD, MBA, MSc

    Celina Yong, MD, MBA, MSc

    Associate Professor of Medicine (Cardiovascular Medicine)

    BioCelina Yong, MD, MBA, MSc is Director of Interventional Cardiology at the Palo Alto VA Medical Center and an Associate Professor in the Division of Cardiovascular Medicine at Stanford. Dr. Yong completed her medical training at Stanford School of Medicine and her internal medicine residency at the University of California, San Francisco. She completed her cardiology and interventional cardiology fellowships at Stanford, including serving as Chief Fellow. As a Marshall Scholar, she completed a Masters in Health Policy, Planning and Financing from the London School of Economics and an MBA from Oxford.

    Dr. Yong’s current research focuses on understanding and reducing inequities in cardiovascular care for patients, as well as resolving gender imbalances in the medical profession itself. She is actively involved in clinical trials of novel devices for percutaneous coronary and structural intervention, and performs structural and coronary interventions at the Palo Alto VA Hospital.

  • Roham Zamanian

    Roham Zamanian

    Professor of Medicine (Pulmonary and Critical Care Medicine)

    Current Research and Scholarly Interests1. Development and evaluation of prognostic and diagnostic integral biomarkers in PAH.

    2. Prevalence and Treatment of Insulin Resistance in PAH.

    3. Role of inflammation and proteomic signature in PAH

    4. Development of novel therapeutics (bench to bedside) including FK506 & Elastase Inhibition in PAH.

    5. Assessment of Vasoreactivity (gain and loss) in pulmonary arterial hypertension

    6. Assessment of microvascular function in PAH.

  • Richard Zare

    Richard Zare

    Marguerite Blake Wilbur Professor of Natural Science and Professor, by courtesy, of Physics
    On Leave from 10/01/2024 To 12/31/2024

    Current Research and Scholarly InterestsMy research group is exploring a variety of topics that range from the basic understanding of chemical reaction dynamics to the nature of the chemical contents of single cells.

    Under thermal conditions nature seems to hide the details of how elementary reactions occur through a series of averages over reagent velocity, internal energy, impact parameter, and orientation. To discover the effects of these variables on reactivity, it is necessary to carry out studies of chemical reactions far from equilibrium in which the states of the reactants are more sharply restricted and can be varied in a controlled manner. My research group is attempting to meet this tough experimental challenge through a number of laser techniques that prepare reactants in specific quantum states and probe the quantum state distributions of the resulting products. It is our belief that such state-to-state information gives the deepest insight into the forces that operate in the breaking of old bonds and the making of new ones.

    Space does not permit a full description of these projects, and I earnestly invite correspondence. The following examples are representative:

    The simplest of all neutral bimolecular reactions is the exchange reaction H H2 -> H2 H. We are studying this system and various isotopic cousins using a tunable UV laser pulse to photodissociate HBr (DBr) and hence create fast H (D) atoms of known translational energy in the presence of H2 and/or D2 and using a laser multiphoton ionization time-of-flight mass spectrometer to detect the nascent molecular products in a quantum-state-specific manner by means of an imaging technique. It is expected that these product state distributions will provide a key test of the adequacy of various advanced theoretical schemes for modeling this reaction.

    Analytical efforts involve the use of capillary zone electrophoresis, two-step laser desorption laser multiphoton ionization mass spectrometry, cavity ring-down spectroscopy, and Hadamard transform time-of-flight mass spectrometry. We believe these methods can revolutionize trace analysis, particularly of biomolecules in cells.

  • Christopher K. Zarins

    Christopher K. Zarins

    Walter Clifford Chidester and Elsa Rooney Chidester Professor of Surgery, Emeritus

    Current Research and Scholarly InterestsHemodynamic factors in atherosclerosis, pathogenesis of, aortic aneurysms, carotid plaque localization and complication, anastomotic intimal hyperplasia, vascular biology of artery wall, computational fluid dynamics as applied to blood flow and vascular disease.

  • James L. Zehnder, M.D.

    James L. Zehnder, M.D.

    Professor of Pathology (Research) and of Medicine (Hematology)
    On Leave from 09/01/2024 To 11/01/2024

    Current Research and Scholarly InterestsMy main research and clinical interests include molecular pathogenesis of acquired cytopenias, genetic testing for inherited non-malignant hematologic disorders, next-generation sequencing approaches to T and B cell clonality testing, somatic mutations in cancer and assessment of minimal residual disease in cancer patients.

  • Huaiyu Zhang

    Huaiyu Zhang

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    BioDr. Zhang obtained her MS in Neuroscience from the University of Southern California and earned her PhD in Clinical Psychology from Emory University. She completed both her predoctoral internship and postdoctoral fellowship at Emory University School of Medicine. Prior to joining Stanford in 2023, Dr. Zhang supported survivors of interpersonal violence at the University of California San Francisco Trauma Recovery Center for over seven years. Dr. Zhang embraces an integrative, contextualized, evidence-informed, and strength-based approach to teaching, supervision, and clinical care. She provides services in English and Mandarin.

  • Renee Zhao

    Renee Zhao

    Assistant Professor of Mechanical Engineering and, by courtesy, of Materials Science and Engineering

    BioRuike Renee Zhao is an Assistant Professor of Mechanical Engineering at Stanford University where she directs the Soft Intelligent Materials Laboratory. Renee received her BS degree from Xi'an Jiaotong University in 2012, and her MS and PhD degrees from Brown University in 2014 and 2016, respectively. She was a postdoc associate at MIT during 2016-2018 prior to her appointment as an Assistant Professor in the Department of Mechanical and Aerospace Engineering at The Ohio State University from 2018 to 2021.

    Renee’s research focuses on the development of stimuli-responsive soft composites for multifunctional robotic systems with integrated shape-changing, assembling, sensing, and navigation. By combining mechanics, polymer engineering, and advanced material manufacturing techniques, the functional soft composites enable applications in soft robotics, miniaturized biomedical devices, flexible electronics, and deployable and morphing structures.

    Renee is a recipient of the ARO Early Career Program (ECP) Award (2023), AFOSR Young Investigator Research Program (YIP) Award (2023), Eshelby Mechanics Award for Young Faculty (2022), ASME Henry Hess Early Career Publication Award (2022), ASME Pi Tau Sigma Gold Medal (2022), ASME Applied Mechanics Division Journal of Applied Mechanics Award (2021), NSF Career Award (2020), and ASME Applied Mechanics Division Haythornthwaite Research Initiation Award (2018).

  • Han Zhu

    Han Zhu

    Assistant Professor of Medicine (Cardiovascular Medicine)

    BioDr. Zhu is an Assistant Professor of Medicine whose clinical and research expertise focuses on cardio-oncology and cardio-immunology. She specializes in the cardiovascular care of patients undergoing therapies for cancer, with a particular focus on the effects of immunotherapies on the heart. She received a bioengineering degree from MIT, medical degree from Case Western Reserve University, and completed clinical cardiology fellowship and internal medicine residency training at Stanford University School of Medicine. Dr. Zhu’s laboratory focuses on myocarditis, cardiac inflammation, and the effects of cancer therapeutics on the cardiovascular system. Her current research employs clinical data, bio-banked samples, and in vivo/in vitro preclinical models in combination with single-cell technologies to study immune-based toxicities in the heart. Dr. Zhu's clinic sees cardio-oncology and cardio-immunology patients and her lab focuses on devising new methods for minimizing cardiovascular complications in the cancer and autoimmune patient populations.